‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
This practice in the health insurance industry may have ‘gotten out of control,’ Wall Street analyst says
How to choose a Medicare Part D prescription drug plan
Base AI policy on evidence, not existential angst
4 possible modern-day factors behind infertility
Skechers draw backlash for full-page ad in Vogue that reeks of AI. ‘You actually didn’t save any money because now I hate you’
Inside the secret history of Design for Good, an alliance between companies with $4 trillion in market cap to devise solutions to the world’s biggest problems
Sam Altman says Trump will ‘lead our country into the age of AI’ as OpenAI gives $1 million to inaugural fund
